Evidence map›Paper›PMID 36741266›Full record

ArticleJournal of Cancer2023

Role of MicroRNA-214 in Dishevelled1-Modulated β-catenin Signalling in Non-Small Cell Lung Cancer Progression.

Huanyu Zhao, Zhao Wang, Guangping Wu, Yudie Lu, Jingrong Zheng, Yue Zhao, Yang Han, Jian Wang, Lianhe Yang, Jiang Du and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Huanyu ZhaoDepartment of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Zhao WangDepartment of Pathology, Beidahuang Industry Group General Hospital, Harbin, Heilongjiang, China.
Guangping WuDepartment of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Yudie LuDepartment of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Jingrong ZhengDepartment of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Yue ZhaoDepartment of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Yang HanDepartment of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Jian WangDepartment of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Lianhe YangDepartment of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Jiang DuDepartment of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
Enhua WangDepartment of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
China Medical University · CNFirst Hospital of China Medical University · CNHeilongjiang Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

coexpressionCTNNB1Dishevelled1microRNA-214non-small cell lung cancer

Identifiers

PMID36741266
PMCPMC9891876
OpenAlexW4313533232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.